Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law write by Amalia Athanasiadou. This book was released on 2018-08-14. Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law available in PDF, EPUB and Kindle. Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals and also the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals. This book is one of the first to critically and comparatively analyse how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by both United States (US) and European courts and enforcement authorities, and to discuss the applicable legal tests and the main criteria used for their assessment. The book’s ultimate objective is to provide guidance to the pharmaceutical industry regarding the types of patent settlements, strategies and conduct which may be problematic from US antitrust and European Union (EU) competition law perspectives and to assist practitioners in structuring settlements which are both efficient and compliant. To this end, an exhaustive legal analysis of some of the most controversial issues regarding pharmaceutical patent settlements is provided, including: – the lengthy split among US Circuit Courts on the issue of pay-for-delay settlements, its resolution by the US Supreme Court in FTC v. Actavisand subsequent jurisprudence; – the decision of Lundbeck v. Commissionby the European General Court and the Servier decision of the European Commission; – the Roche/Novartisdecision of the European Court of Justice and the most important decisions by National Competition Authorities on pharma patent settlements in the EU; – an overview of other types of strategies such as product-hopping and product reformulations, no-authorised generic commitments, problematic side-deals, mechanisms affecting generic substitution; – the rejection of the “scope of the patent” test in both the US and the EU and the balancing of patent law and antitrust law considerations in the prevailing applicable tests; – the benefits of settlements and the main criteria for assessing their legitimacy under US antitrust and EU competition law. The analysis provides concrete examples of both illegitimate and legitimate settlements and strategies, emphasising on conduct that falls within a grey zone and on the circumstances and criteria under which such conduct could be deemed problematic from an antitrust perspective. This book will serve as a valuable guide for pharmaceutical companies wishing to minimise the risk of engaging in conduct that could potentially infringe US antitrust and EU competition law. It further aims to save courts and enforcement agencies and also practitioners and academics considerable time and resources by providing an exhaustive analysis of the relevant caselaw, with the ultimate goal to increase legal certainty on the most controversial aspects of patent settlements in the pharmaceutical industry.
Patent Settlements in the Pharmaceutical Industry
Patent Settlements in the Pharmaceutical Industry - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Patent Settlements in the Pharmaceutical Industry write by Jonas Frank. This book was released on 2016. Patent Settlements in the Pharmaceutical Industry available in PDF, EPUB and Kindle. Patent settlements between originator and generic firms in the pharmaceutical industry are a controversial topic, both in EU competition policy and U.S. antitrust law. The main concern is that patent settlements, which involve large payments from the originator to generic firms (reverse payments) and simultaneously restrict or delay market entry of generic firms, might have to be regarded as anti-competitive agreements that protect weak and perhaps unjustified patents from challenges. Therefore, certain types of patent settlements might harm consumers, both by defending unjustifiable patents and restricting competition by generic firms. In this article, we use the dispute in U.S. antitrust law between the U.S. antitrust authorities and various U.S. courts about how to deal with patent settlements with reverse payments as a starting point for an economic analysis of this problem. We particularly focus on two aspects: (1) Patent settlements have also to be seen as potentially endangering the already weak mechanisms within patent law for challenging and weeding out weak patents. (2) The incentives for originator and generic firms for negotiating patent settlements depend crucially on the entire institutional framework in pharmaceutical markets. Therefore, the competitive assessment of patent settlements requires the analysis of the interplay between patent law rules, the regulations for drug approval (FDA regulations in the U.S.), antitrust law rules, and, in the U.S., the Hatch-Waxman Act with its specific rules for the relation between originator and generic firms. Important conclusions are the need for a much deeper analysis of this interplay of different regulations, and the insight that the U.S. criteria for assessing patent settlements might not be directly transferable to the EU, due to different institutional frameworks for pharmaceutical markets.
Competition in the Pharmaceutical Marketplace
Competition in the Pharmaceutical Marketplace - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Competition in the Pharmaceutical Marketplace write by United States. Congress. Senate. Committee on the Judiciary. This book was released on 2002. Competition in the Pharmaceutical Marketplace available in PDF, EPUB and Kindle.
Reverse Payment Patent Settlements in the Pharmaceutical Sector Under EU and US Competition Laws
Reverse Payment Patent Settlements in the Pharmaceutical Sector Under EU and US Competition Laws - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Reverse Payment Patent Settlements in the Pharmaceutical Sector Under EU and US Competition Laws write by Margherita Colangelo. This book was released on 2017. Reverse Payment Patent Settlements in the Pharmaceutical Sector Under EU and US Competition Laws available in PDF, EPUB and Kindle. Within the tool-box developed by originator companies in order to prepare and respond to generic entry, a prominent position must be recognized to a category of patent strategies particularly controversial under antitrust scrutiny, i.e. patent settlement agreements, in particular in the form of reverse payment patent settlements (also called pay-for-delay settlements), due to the fact that they provide for the patentee to pay the alleged infringer, rather than the opposite, with the aim of delaying its market entry. It is a fact that reverse payment settlement agreements arise mainly in the pharmaceutical industry. The paper firstly analyzes US and EU regulatory frameworks in order to highlight similarities and differences between them. Then, it examines the relevant case law in both contexts with a view to conducting a comparative study. Finally, the paper discusses the approaches to reverse payment patent settlements adopted by antitrust authorities and courts and their clashes with IP law, and contains a final proposal for the assessment of these agreements.
Competition and Patent Law in the Pharmaceutical Sector
Competition and Patent Law in the Pharmaceutical Sector - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Competition and Patent Law in the Pharmaceutical Sector write by Giovanni Pitruzzella. This book was released on 2016. Competition and Patent Law in the Pharmaceutical Sector available in PDF, EPUB and Kindle. Editors --Contributors --Foreword --Preface --Pharmaceutical Patents and Competition Issues --What Is Going on in National Systems?
